Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and sells vaccines to domestic and international markets for biological products. The vaccine's proprietary method for human-derived transplantation to the scaffold promotes bone and tissue growth. These products are used in a variety of applications, including enhancing fusion in spinal surgery, stabilizing facet joints to relieve back pain, promoting bone growth in foot and ankle surgery, neurosurgery in knee surgery after skull healing, and promoting regeneration. 

XTNT

XTNT Profile